5Nielsen R,Levander S,Kjaersdam-Telléus G,et al.Secondgeneration antipsychotic effect on cognition in patients with schizophrenia——a meta-analysis of randomized clinical trials[J].Acta Psychiatr Scand,2015,131(3):185-196.
6Jiang Y,Ni W,McGinnis J.Comparison of health services use associated with ziprasidone and olanzapine among schizophrenia and bipolar disorder patients in the USA[J].Clin Drug Investig,2014,34(7):491-499.
7Soares-Weiser K,Béchard-Evans L,Lawson AH,et al.Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia:a systematic review and meta-analysis[J].Eur Neuropsychopharmacol,2013,23(2):118-125.
8Sakurai H,Bies R,Stroup S,et al.Dopamine D2receptor occupancy and cognition in schizophrenia:analysis of the CATIE data[J].Schizophr Bull,2013,39(3):564-574.
9Rummel-Kluge C,Komossa K,Schwarz S,et al.Head-tohead comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia:a systematic review and meta-analysis[J].Schizophr Res,2010,123(2/3):225-233.
